PT1016711E - Processo de inactivacao de virus de envelope numa preparacao viral de adenovirus - Google Patents

Processo de inactivacao de virus de envelope numa preparacao viral de adenovirus

Info

Publication number
PT1016711E
PT1016711E PT99403194T PT99403194T PT1016711E PT 1016711 E PT1016711 E PT 1016711E PT 99403194 T PT99403194 T PT 99403194T PT 99403194 T PT99403194 T PT 99403194T PT 1016711 E PT1016711 E PT 1016711E
Authority
PT
Portugal
Prior art keywords
viral preparation
virus inactivation
preparation
inactivation process
envelope virus
Prior art date
Application number
PT99403194T
Other languages
English (en)
Inventor
Gaillac David
Koehl Michel
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of PT1016711E publication Critical patent/PT1016711E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10361—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10361—Methods of inactivation or attenuation
    • C12N2710/10363—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
PT99403194T 1998-12-21 1999-12-17 Processo de inactivacao de virus de envelope numa preparacao viral de adenovirus PT1016711E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9816147A FR2787465A1 (fr) 1998-12-21 1998-12-21 Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes

Publications (1)

Publication Number Publication Date
PT1016711E true PT1016711E (pt) 2005-02-28

Family

ID=9534248

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99403194T PT1016711E (pt) 1998-12-21 1999-12-17 Processo de inactivacao de virus de envelope numa preparacao viral de adenovirus

Country Status (11)

Country Link
US (2) US7026154B1 (pt)
EP (1) EP1016711B1 (pt)
JP (1) JP4459353B2 (pt)
AT (1) ATE280823T1 (pt)
AU (1) AU769121B2 (pt)
CA (1) CA2292922C (pt)
DE (1) DE69921435T2 (pt)
DK (1) DK1016711T3 (pt)
ES (1) ES2230820T3 (pt)
FR (1) FR2787465A1 (pt)
PT (1) PT1016711E (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1420065A4 (en) * 2001-08-02 2005-03-09 Anges Mg Inc PROCESS FOR PRODUCING INACTIVE VIRAL ENVELOPES
US7056723B2 (en) * 2001-12-20 2006-06-06 Bavarian Nordic A/S Method for the recovery and purification of poxviruses from infected cells
DE602004031681D1 (de) 2003-07-21 2011-04-14 Transgene Sa Multifunktionelle Cytokine
US20050197496A1 (en) * 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
US20060130159A1 (en) * 2004-12-09 2006-06-15 Nick Masiello Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
US7531632B2 (en) * 2006-02-16 2009-05-12 Gtc Biotherapeutics, Inc. Clarification of transgenic milk using depth filtration
PE20081723A1 (es) 2007-01-30 2008-12-14 Transgene Sa Vacuna contra el papilomavirus
MX2011007386A (es) 2009-01-20 2011-08-03 Transgene Sa Icam-1 soluble como un biomarcador para la prediccion de una respuesta terapeutica.
WO2010108908A1 (en) 2009-03-24 2010-09-30 Transgene Sa Biomarker for monitoring patients
JP5661738B2 (ja) 2009-04-17 2015-01-28 トランジェーヌ、ソシエテ、アノニムＴｒａｎｓｇｅｎｅ Ｓ．Ａ． 患者をモニターするためのバイオマーカー
CA2767458A1 (en) 2009-07-10 2011-01-13 Bruce Acres Biomarker for selecting patients and related methods
BR112012002628B1 (pt) 2009-08-07 2021-09-08 Transgene Sa Composição imunogênica, molécula de ácido nucleico, vetor, partícula viral infecciosa, micro-organismo transgênico, composição, usos da composição imunogênica e kit de partes
JP2013523175A (ja) 2010-04-14 2013-06-17 イーエムディー・ミリポア・コーポレーション 高力価、高純度のウイルスストックの作製方法及びその使用方法
US9029517B2 (en) 2010-07-30 2015-05-12 Emd Millipore Corporation Chromatography media and method
SG191781A1 (en) * 2010-12-30 2013-08-30 Lab Francais Du Fractionnement Glycols as pathogen inactivating agents
EP3587455A1 (en) 2012-10-23 2020-01-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
US10449517B2 (en) 2014-09-02 2019-10-22 Emd Millipore Corporation High surface area fiber media with nano-fibrillated surface features
US20170298091A1 (en) 2014-12-08 2017-10-19 Emd Millipore Corporation Mixed Bed Ion Exchange Adsorber
ES3011733T3 (en) 2015-02-13 2025-04-08 Transgene Immunotherapeutic vaccine and antibody combination therapy
WO2016131945A1 (en) 2015-02-20 2016-08-25 Transgene Sa Combination product with autophagy modulator
EP3452081A1 (en) 2016-05-04 2019-03-13 Transgene SA Combination therapy with cpg tlr9 ligand
EP3522920A2 (en) 2016-10-10 2019-08-14 Transgene SA Immunotherapeutic product and mdsc modulator combination therapy
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
US11690869B2 (en) * 2020-04-23 2023-07-04 Johnson & Johnson Consumer Inc. Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2007545A1 (en) * 1989-01-13 1990-07-13 Yahiro Uemura Production method for protein-containing composition
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
US6281010B1 (en) * 1995-06-05 2001-08-28 The Trustees Of The University Of Pennsylvania Adenovirus gene therapy vehicle and cell line
DE19623293C2 (de) * 1996-06-11 1998-10-22 Biotest Pharma Gmbh Nicht-immunogene Faktor VIII-enthaltende Zusammensetzung und ein Verfahren zu ihrer Herstellung
ATE353956T1 (de) * 1996-12-13 2007-03-15 Schering Corp Methoden zur virus-reinigung
DE19709186C2 (de) * 1997-03-06 1999-10-14 Medigene Ag Filtrationsverfahren zur Trennung von Viren

Also Published As

Publication number Publication date
AU769121B2 (en) 2004-01-15
US7026154B1 (en) 2006-04-11
JP2000201673A (ja) 2000-07-25
DK1016711T3 (da) 2005-03-07
JP4459353B2 (ja) 2010-04-28
AU6535899A (en) 2000-06-22
ES2230820T3 (es) 2005-05-01
US7378265B2 (en) 2008-05-27
DE69921435D1 (de) 2004-12-02
EP1016711B1 (fr) 2004-10-27
FR2787465A1 (fr) 2000-06-23
ATE280823T1 (de) 2004-11-15
CA2292922A1 (fr) 2000-06-21
US20060166345A1 (en) 2006-07-27
DE69921435T2 (de) 2006-03-02
EP1016711A1 (fr) 2000-07-05
CA2292922C (fr) 2011-05-31

Similar Documents

Publication Publication Date Title
DK1016711T3 (da) Fremgangsmåde til inaktivering af kappeklædte virus i et viruspræparat med adenovirus
AR020054A1 (es) COMPOSICIoN QUE COMPRENDE UN ADENOVIRUS
ATE333849T1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
DE69629209D1 (de) Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose
GB2085880B (en) 1-carboxyalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing thhese compounds and their therapeutic application
NO993247L (no) Fremgangsmåte for fremstilling av tolterodin
ES8307500A1 (es) "metodo para inactivar los virus infecciosos contenidos en una composicion enzimatica hemocoagulante".
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
PT1149910E (pt) Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
IT1126348B (it) Enzima immobilizzato,procedimenti per la preparazione di detto enzima nonche' procedimento per effettuare una reazione enzimatica
ATE233086T1 (de) Wirkstoffhaltige pflaster
AU7554987A (en) Solutions of oxazaphosphorins having improved stability and process for the preparation thereof
ES2159938T3 (es) Preparados transdermicos, orales e intravenosos de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona.
FI925210A7 (fi) Kokoonpanot ja menetelmät RNA-molekyylin aktiivisuuden moduloimiseksi RNA-molekyylin 5'-pään cap-rakenteen modifioimisella
FI952482A7 (fi) Uusi menetelmä taksaanijohdannaisten valmistamiseksi, näin saadut johd annaiset ja niitä sisältävät koostumukset
MX9800802A (es) Nueva composicion reductora y nuevo procedimiento para la deformacion permanente de los cabellos.
NO895002D0 (no) Enzymhemmende aminosyrederivater.
DE59909258D1 (de) Färbemittel mit enzymen
AU2979899A (en) Treatment of viral disease in swine
BR9807785A (pt) Processo para a preparação do composto, e, composto
DE69636456D1 (de) In-vitro verpackung von adeno-assozierten virus dns
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
ATE118763T1 (de) Phenolisches amin als antimelanoma- und depigmentierungsmittel.
DE69829174D1 (de) Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein)